Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules (Q35552828)

8 August 2017

1 reference

title

Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules (English)

1 reference

8 August 2017

1 reference

Giovanni Passalacqua

1 reference

8 August 2017

Giorgio Walter Canonica

series ordinal

object named as

Giorgio Walter Canonica

1 reference

8 August 2017

Giorgio Ciprandi

1 reference

8 August 2017

Maria Angela Tosca

1 reference

8 August 2017

Cristina Cosentino

1 reference

8 August 2017

Anna Maria Riccio

series ordinal

1 reference

8 August 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

The Journal of Allergy and Clinical Immunology

8 August 2017

published in

1 reference

8 August 2017

volume

112

1 reference

8 August 2017

issue

4 Suppl

1 reference

8 August 2017

page(s)

S78-82

1 reference

Adhesion receptors of the immune system

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

A possible role for adhesion molecules in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Adhesion molecules in allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Allergic subjects express intercellular adhesion molecule--1 (ICAM-1 or CD54) on epithelial cells of conjunctiva after allergen challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Allergen-specific challenge induces intercellular adhesion molecule 1 (ICAM-1 or CD54) on nasal epithelial cells in allergic subjects. Relationships with early and late inflammatory phenomena

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

A mechanism for the antiinflammatory effects of corticosteroids: the glucocorticoid receptor regulates leukocyte adhesion to endothelial cells and expression of endothelial-leukocyte adhesion molecule 1 and intercellular adhesion molecule 1

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Regulation of leukocyte-endothelial interactions by glucocorticoids.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Corticosteroids inhibit rhinovirus-induced intercellular adhesion molecule-1 up-regulation and promoter activation on respiratory epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Inhibition of VCAM-1 expression in human bronchial epithelial cells by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Circulating ICAM-1 levels in bronchial asthma and the effect of inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Soluble intercellular adhesion molecule 1 (ICAM-1) antigen in sera of bronchial asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Serologic study of the working mechanisms of immunotherapy for children with perennial allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Adhesion molecules of allergic inflammation: recent insights into their functional roles.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Topical ocular levocabastine reduces ICAM-1 expression on epithelial cells both in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Terfenadine and fexofenadine reduce in vitro ICAM-1 expression on human continuous cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Seasonal rhinitis and azelastine: long- or short-term treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early- and late-phase reactions after allergen-specific challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Cetirizine reduces ICAM-I on epithelial cells during nasal minimal persistent inflammation in asymptomatic children with mite-allergic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Terfenadine exerts antiallergic activity reducing ICAM-1 expression on nasal epithelial cells in patients with pollen allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Loratadine treatment of rhinitis due to pollen allergy reduces epithelial ICAM-1 expression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Loratadine reduces the expression of ICAM-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Continuous Versus On Demand Treatment with Cetirizine for Allergic Rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Continuous antihistamine treatment controls allergic inflammation and reduces respiratory morbidity in children with mite allergy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Fexofenadine: a review of its use in the management of seasonal allergic rhinitis and chronic idiopathic urticaria

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

Pharmacokinetics, pharmacodynamics, and tolerance of single- and multiple-dose fexofenadine hydrochloride in healthy male volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2803%2901880-3

7 January 2021

10.1016/S0091-6749(03)01880-3

Identifiers

DOI

1 reference

8 August 2017

1 reference